The CostSimplified® virtual health rental program expands offerings with newly added telehealth delivery stations and medical devices.Continue reading
Author Archive: AZBio
Meet the 2021 Arizona Innovation Challenge Awardees
ARIZONA COMMERCE AUTHORITY ANNOUNCES AWARDEES FOR THE 2021 ARIZONA INNOVATION CHALLENGE
Of the ten awardees, five are bio & life science companies: Navi Nurses, ReSuture, SaiOx Inc., TapRoot Interventions & Solutions, and The Patient Company
Continue reading
NeoLight Acquires Phoenix Technology Group
Scottsdale, AZ, Nov 17, 2021—NeoLight LLC (NeoLight), an ASU spinout and an Arizona based newborn medical device company, today announced it has acquired Phoenix Technology Group LLC (PTG), a leading provider of advanced ophthalmic imaging devices, including a telemedicine platform for retinopathy of prematurity (ROP) screening, a leading cause of blindness in premature infants. The acquisition will expand the NeoLight product portfolio to include the ocular imaging devices Phoenix ICON™, Phoenix ICON™ GO, and the telemedicine platform Phoenix CONNECT™ (previously known as FocusROP). These products provide advanced ocular imaging through lens and light innovation, providing stunning ocular images that give clinicians the needed speed, confidence, and connectivity for patient exams.Continue reading
TGen’s Annual Economic Impact on Arizona Exceeds Half a Billion Dollars
Latest economic-impact report shows that TGen returns $132 for every $1 invested by the State of ArizonaContinue reading
Health Futures: Joan Koerber-Walker and Bob Roth Discuss Health Innovation
AZBio president & CEO, Joan Koerber-Walker, joins Bob Roth on Health Futures to discuss health innovation, the importance of making good choices during the pandemic, and why AZBio is helping to build AZAdvances. Continue reading
UArizona Researcher Will Screen Drug Combos That Might Lengthen Our Lives
Funded by the National Academy of Medicine, Dr. George Sutphin will conduct a high-throughput screen of life-extending compounds in roundworms.Continue reading
UArizona Researchers Develop Ultra-Thin ‘Computer on the Bone’
Engineers and physicians teamed up to develop a wireless device to monitor and protect bone health.Continue reading
Life Science Leaders Weigh In On Build Back Better Provisions
On Friday, November 19, 2021, the U.S. House of Representatives passed the Build Back Better bill on a 220-213 vote. The bill now moves to the Senate for further review and action. Valued at close to $2 trillion, the bill includes a potpourri of Democratic social spending priorities that includes free preschool for 3 and 4 year old children, initiatives to fight climate change and affordable housing programs. The bill also includes increases to Pell grants for college tuition, expands family leave, and provides new hearing benefit for seniors. It also incudes “pay fors” including increases corporate taxes, funds additional resources for IRS enforcement, AND implements price controls on certain medicines. Investors and life science companies of all sizes have expressed serious concerns that if the latter provisions pass the Senate and are implemented the impact on future health innovation could be devastating. Continue reading
Regents approve universities’ three-year Technology and Research Initiative Fund plans for FY 2022
The Arizona Board of Regents has approved new, three-year funding proposals from Arizona State University, Northern Arizona University and the University of Arizona that will enable critical technology and research advancements through the Technology and Research Initiative Fund. Continue reading
Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine Boosters
November 19, 2021: Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will meet later today to discuss further clinical recommendations.Continue reading